Mingchao WANG - Advanced Drug Delivery and Biomaterials (ADDB)
Development of doxorubicin-based nanomedicine for the local treatment of glioblastoma
Promotors: Véronique Préat (UCLouvain) and Chiara Bastiancich (Aix-Marseille Université / Université de Turin)
Related references:
- Wang M, Bergès R, Malfanti A, Préat V, Bastiancich C. Local delivery of doxorubicin prodrug via lipid nanocapsule-based hydrogel for the treatment of glioblastoma. Drug Deliv Transl Res. 2023 doi: 10.1007/s13346-023-01456-y.
- Wang M, Malfanti A, Bastiancich C, Préat V. Synergistic effect of doxorubicin lauroyl hydrazone derivative delivered by α-tocopherol succinate micelles for the treatment of glioblastoma. Int J Pharm X. 5:100147 (2022). doi: 10.1016/j.ijpx.2022.100147.
This thesis defence took place on December 18, 2023